Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.32 USD | +2.03% | -6.11% | -24.14% |
Apr. 09 | UBS Adjusts Denali Therapeutics Price Target to $32 From $70, Maintains Buy Rating | MT |
Apr. 03 | Denali Therapeutics Insider Sold Shares Worth $1,896,250, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.14% | 2.28B | |
-0.41% | 103B | |
+3.58% | 96.73B | |
+1.66% | 21.31B | |
-16.33% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-23.39% | 13.68B | |
+5.85% | 13.44B | |
+22.97% | 10.98B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Transcript : Denali Therapeutics Inc. - Analyst/Investor Day